Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 9/20 | 0.51 |
| ▸ | REN | P00797 | 4/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | F2 | P00734 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | PEPD | P12955 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | HRH1 | P35367 | 1/20 | 0.51 |
| ▸ | THPO | P40225 | 1/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.51 |
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.48 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30008142 | 1.00 | ACE (0.51) | ACERENKDM4EF2LMNA | |
| SCHEMBL30399601 | 0.93 | ACE (0.45) | ACERENKDM4EF2LMNA | |
| SCHEMBL7757811 | 0.90 | ACE (0.61) | ACERENKDM4EF2LMNA | |
| SCHEMBL10733124 | 0.90 | ACE (0.61) | ACERENKDM4EF2LMNA | |
| SCHEMBL30661451 | 0.90 | MEN1 (0.47) | ACERENKDM4EF2LMNA | |
| SCHEMBL29794187 | 0.89 | ACE (0.50) | ACERENKDM4EF2LMNA | |
| SCHEMBL29547044 | 0.89 | ACE (0.53) | ACERENKDM4EF2LMNA | |
| SCHEMBL31214680 | 0.89 | ACE (0.52) | ACERENKDM4EF2LMNA | |
| SCHEMBL29470154 | 0.89 | ACE (0.52) | ACERENKDM4EF2LMNA | |
| SCHEMBL12966251 | 0.89 | ACE (0.52) | ACERENKDM4EF2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7449 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310641-A1 | Site-specific antibody conjugation and its use | HOFFMANN-LA ROCHE INC. (US) | 2023-10-05 | — | — | US | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| US-20220170066-A1 | DIFFERENTIATION OF LYME DISEASE AND SOUTHERN TICK-ASSOCIATED RASH ILLNESS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2022-06-02 | — | — | US | claimed |
| US-11230728-B2 | Differentiation of lyme disease and southern tick-associated rash illness | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2022-01-25 | — | — | US | claimed |
| CN-108290931-B | Novel polypeptides having affinity for PD-L1 | AFFIBODY AB (SE) | 2026-05-26 | — | — | CN | disclosed |
| CN-114867527-B | Macrocyclic peptides | Herantis pharmaceutical Co. (FI) | 2026-05-26 | — | — | CN | disclosed |
| CN-114729002-B | Eluent collection during antibody chromatography | MORPHOSYS AG (DE) | 2026-05-26 | — | — | CN | disclosed |
| CN-115038722-B | Antibodies against KLK5 | UCB biopharmaceutical Co.,Ltd. (BE) | 2026-05-26 | — | — | CN | disclosed |
| CN-116348115-B | Combination of antibody-drug conjugate and PARP1 selective inhibitor | ASTRAZENECA UK LTD. (GB) | 2026-05-26 | — | — | CN | disclosed |
| CN-116410307-B | Neutralizing antibody for neutralizing SARS-CoV-2 in six strains and its application | TSINGHUA UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-113583116-B | Antibodies against SARS-CoV-1 or SARS-CoV-2 and uses thereof | 养生堂有限公司 | 2026-05-22 | — | — | CN | disclosed |
| CN-115135669-B | Modified Fc region | 硕腾服务有限责任公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-107206072-B | Combination therapy of the T cell activating bispecific antigen binding molecule CD3 ABD folate receptor 1(FolR1) and a PD-1 axis binding antagonist | 豪夫迈·罗氏有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113966344-A | anti-BCMA antibody conjugates, compositions comprising the same, and methods of making and using the same | 细胞基因公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-107847592-B | Antibodies against human CSF-1R for inducing lymphocytosis in lymphomas or leukemias | 豪夫迈·罗氏有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-107001460-B | Selective reduction of cysteine residues in IL-17 antibodies | 诺华股份有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113956358-A | anti-TIGIT antibodies and methods of use | 豪夫迈·罗氏有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-107586340-B | Bispecific antibodies specific for T cell activating antigens and tumor antigens and methods of use | 罗切格利卡特公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113957065-A | Sucrose isomerase with high conversion rate and application thereof | 南京诺云生物科技有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113957061-A | Administration of kynurenine depleting enzymes for tumor therapy | 得克萨斯大学体系董事会 | 2022-01-21 | — | — | CN | disclosed |